Description: Cryo-Cell International, Inc. engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative medicine to treat a range of conditions, including heart, and kidney disease, ALS, wound healing, auto-immune diseases, multiple sclerosis, Alzheimer's disease, Parkinson's diseases. The company manufactures and sells PrepaCyte CB processing system, a technology used to process umbilical cord blood stem cells. It markets its cord blood stem cell preservation services directly to expectant parents, as well as by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals. Cryo-Cell International, Inc. was incorporated in 1989 and is headquartered in Oldsmar, Florida.
Home Page: www.cryo-cell.com
700 Brooker Creek Boulevard
Oldsmar,
FL
34677
United States
Phone:
813 749 2100
Officers
Name | Title |
---|---|
Mr. David I. Portnoy | Chairman & Co-CEO |
Mr. Mark L. Portnoy | Co-CEO & Director |
Ms. Jill M. Taymans | CFO & VP of Finance |
Mr. Oleg Mikulinsky | Chief Information Officer |
Dr. Joanne Kurtzberg M.D. | Medical Director and Member of Medical & Scientific Advisory Board |
Exchange: F
Country: DE : Germany
Currency: Euro (€)
GIC Sector: | Health Care |
---|---|
GIC Group: | Health Care Equipment & Services |
GIC Industry: | Health Care Providers & Services |
GIC Sub-Industry: | Health Care Facilities |
Forward PE: | 0 |
---|---|
Trailing PE: | 0 |
Price-to-Book MRQ: | 0 |
Price-to-Sales TTM: | 2.1343 |
IPO Date: | |
Fiscal Year End: | November |
Full Time Employees: | 82 |